Diasorin Spa Stock Performance
| DSRLF Stock | USD 102.64 4.21 3.94% |
The firm shows a Beta (market volatility) of -0.0578, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning DiaSorin SpA are expected to decrease at a much lower rate. During the bear market, DiaSorin SpA is likely to outperform the market. At this point, DiaSorin SpA has a negative expected return of -0.0763%. Please make sure to confirm DiaSorin SpA's total risk alpha, and the relationship between the standard deviation and daily balance of power , to decide if DiaSorin SpA performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days DiaSorin SpA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable essential indicators, DiaSorin SpA is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 339.9 M | |
| Total Cashflows From Investing Activities | -1.6 B | |
| Free Cash Flow | 283.3 M |
DiaSorin |
DiaSorin SpA Relative Risk vs. Return Landscape
If you would invest 10,788 in DiaSorin SpA on November 3, 2024 and sell it today you would lose (524.00) from holding DiaSorin SpA or give up 4.86% of portfolio value over 90 days. DiaSorin SpA is currently producing negative expected returns and takes up 0.5355% volatility of returns over 90 trading days. Put another way, 4% of traded pink sheets are less volatile than DiaSorin, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
DiaSorin SpA Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for DiaSorin SpA's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as DiaSorin SpA, and traders can use it to determine the average amount a DiaSorin SpA's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1425
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | DSRLF |
Estimated Market Risk
| 0.54 actual daily | 4 96% of assets are more volatile |
Expected Return
| -0.08 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.14 actual daily | 0 Most of other assets perform better |
Based on monthly moving average DiaSorin SpA is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of DiaSorin SpA by adding DiaSorin SpA to a well-diversified portfolio.
DiaSorin SpA Fundamentals Growth
DiaSorin Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of DiaSorin SpA, and DiaSorin SpA fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on DiaSorin Pink Sheet performance.
| Return On Equity | 0.2 | |||
| Return On Asset | 0.0902 | |||
| Profit Margin | 0.20 % | |||
| Operating Margin | 0.29 % | |||
| Current Valuation | 8.64 B | |||
| Shares Outstanding | 53.84 M | |||
| Price To Earning | 26.36 X | |||
| Price To Book | 4.73 X | |||
| Price To Sales | 5.56 X | |||
| Revenue | 1.24 B | |||
| EBITDA | 517.3 M | |||
| Cash And Equivalents | 382.44 M | |||
| Cash Per Share | 7.06 X | |||
| Total Debt | 1.23 B | |||
| Debt To Equity | 0.93 % | |||
| Book Value Per Share | 30.10 X | |||
| Cash Flow From Operations | 400.66 M | |||
| Earnings Per Share | 5.34 X | |||
| Total Asset | 3.23 B | |||
| Retained Earnings | 94 M | |||
| Current Asset | 361 M | |||
| Current Liabilities | 117 M | |||
About DiaSorin SpA Performance
By analyzing DiaSorin SpA's fundamental ratios, stakeholders can gain valuable insights into DiaSorin SpA's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if DiaSorin SpA has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if DiaSorin SpA has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company was founded in 1968 and is headquartered in Saluggia, Italy. DIASORIN SPA operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 3350 people.Things to note about DiaSorin SpA performance evaluation
Checking the ongoing alerts about DiaSorin SpA for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for DiaSorin SpA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| DiaSorin SpA generated a negative expected return over the last 90 days | |
| About 58.0% of the company shares are held by company insiders |
- Analyzing DiaSorin SpA's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether DiaSorin SpA's stock is overvalued or undervalued compared to its peers.
- Examining DiaSorin SpA's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating DiaSorin SpA's management team can have a significant impact on its success or failure. Reviewing the track record and experience of DiaSorin SpA's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of DiaSorin SpA's pink sheet. These opinions can provide insight into DiaSorin SpA's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for DiaSorin Pink Sheet analysis
When running DiaSorin SpA's price analysis, check to measure DiaSorin SpA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DiaSorin SpA is operating at the current time. Most of DiaSorin SpA's value examination focuses on studying past and present price action to predict the probability of DiaSorin SpA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DiaSorin SpA's price. Additionally, you may evaluate how the addition of DiaSorin SpA to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |